Filip Basta

Filip Basta

Auto-generated profile, based on publicly available information

Filip Basta

Medical University of Silesia in Katowice

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 March 2026 in Lekarz Wojskowy
Verified
Journal Article
Open access
DKDominik Ireneusz Kret
Dominik Ireneusz Kret
WSWiktoria Klaudia Szlachta
Wiktoria Klaudia Szlachta
AAAntoni Anczyk
Antoni Anczyk
KHKarolina Handzel
Karolina Handzel
GZGrzegorz Zaborowski
Grzegorz Zaborowski
MTMiłosz Tworek
Miłosz Tworek
Aim of the paper: To present a systematic review of the scientific literature on the hypoglycaemic effects of garlic (Allium sativum L.), with a focus on its mechanisms of action, clinical efficiency, and potential adverse effects. Materials and methods: Publications from 2015 to 2024 available in the PubMed, Scopus, and Web of Science databases were analysed. These included randomised clinical trials, meta-analyses, and systematic reviews. Results: The collected data suggest that garlic supplementation, particularly in its natural form, can significantly reduce fasting blood glucose levels, with more pronounced effects observed over longer intervention periods. Some studies also report positive effects on glycated haemoglobin, postprandial glucose, and fructosamine levels. The proposed mechanisms of action include increased insulin secretion, improved tissue sensitivity to insulin, and modulation of oxidative and inflammatory processes. Conclusions: The evidence indicates that garlic has considerable potential as a natural adjunct in the prevention and treatment of metabolic disorders. However, further large-scale clinical trials are required to conclusively confirm its efficacy and safety.

27 March 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
SJSzymon Janczarski
Szymon Janczarski
ABAleksandra Banaś
Aleksandra Banaś
DSDominika Sarna
Dominika Sarna
PWPiotr Widera
Piotr Widera
MMMaciej Michalik
Maciej Michalik
HDHubert Dacyl
Hubert Dacyl
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia worldwide and represents a major contributor to stroke, heart failure, and cardiovascular mortality. A significant proportion of AF cases remain asymptomatic, often referred to as "silent AF," which delays diagnosis and increases the risk of severe thromboembolic complications. Conventional diagnostic methods, including standard electrocardiography (ECG) and short-term Holter monitoring, are limited by their episodic nature and reliance on clinical settings, frequently failing to capture intermittent arrhythmic events. In recent years, consumer wearable technologies - particularly smartwatches equipped with photoplethysmography (PPG) sensors and single-lead ECG capabilities - have emerged as promising tools for continuous cardiac rhythm monitoring. This narrative review synthesizes contemporary evidence on the diagnostic accuracy, clinical integration, and behavioral implications of wearable technologies for AF detection. Literature published between 2018 and 2025 was identified through searches of PubMed/MEDLINE, Scopus, and Google Scholar. Studies evaluating sensing technologies, algorithmic approaches, large-scale population trials, and digital health behavior were included. Current evidence demonstrates that wearable devices can achieve high concordance with traditional ECG-based diagnostic methods, with many studies reporting sensitivities and specificities exceeding 90%. Passive PPG monitoring combined with user-initiated ECG confirmation enables scalable detection of previously undiagnosed AF in real-world settings. However, challenges remain, including signal artifacts, false-positive alerts, user adherence, and socioeconomic disparities in device access. Overall, wearable technologies represent a valuable adjunct for early AF detection and long-term rhythm monitoring. Their optimal clinical role lies within hybrid diagnostic pathways that integrate patient-generated data with physician validation and established cardiovascular care frameworks.

23 April 2026 in Quality in Sport
Verified
Journal Article
Open access
PDF file
BWBartosz Wróbel
Bartosz Wróbel
LWLena Wójcik
Lena Wójcik
MFMichał Filipski
Michał Filipski
KPKuba Ptaszkiewicz
Kuba Ptaszkiewicz
FBFilip Basta
Filip Basta
Matcha green tea, a powdered whole-leaf preparation from shade-grown Camellia sinensis, exhibits a unique biochemical profile rich in catechins (particularly EGCG), L-theanine, caffeine, and chlorophyll, distinguishing it from conventional green teas. This narrative review synthesizes evidence on matcha's composition, mechanisms of action, and health effects. Mechanistically, EGCG activates the Nrf2/Keap1 antioxidant pathway, suppresses inflammatory signaling, and synergizes with L-theanine/caffeine to enhance cognitive function, while modulating gut microbiota toward beneficial taxa like Coprococcus. Clinical and preclinical studies demonstrate cardiometabolic benefits including improved glycemic control, lipid profiles, and hepatic protection against NAFLD, alongside cognitive enhancements and reduced exercise-induced fatigue. Preliminary data suggest anti-cancer potential via apoptosis induction and metabolic inhibition in tumor cells. Despite promising mechanistic insights, human trials remain limited by small samples, short durations, and heterogeneous preparations. Matcha emerges as a functional food with multifaceted health potential, warranting large-scale randomized controlled trials to establish optimal dosing, long-term efficacy, and safety for evidence-based recommendations.

30 June 2026 in Lekarz Wojskowy
Verified
Journal Article
Open access
KHKarolina Magdalena Handzel
Karolina Magdalena Handzel
AAAntoni Anczyk
Antoni Anczyk
FBFilip Basta
Filip Basta
JWJacek Wysoczański
Jacek Wysoczański
MTMiłosz Tworek
Miłosz Tworek
DKDominik Ireneusz Kret
Dominik Ireneusz Kret
Background: Population aging poses significant challenges in the context of cognitive function maintenance. This review aims to compare the effectiveness of various forms of physical activity, including aerobic, resistance, and mind–body exercise, in improving key cognitive domains, with a particular focus on the older adult population. Methods: A systematic review of recent scientific literature was conducted, focusing on meta-analyses and systematic reviews available in Google Scholar and PubMed, using keywords related to physical exercise, cognitive functions, aging, and forms of physical activity. Results: The analysis revealed that each training modality has a specific benefit profile. Mind–body exercises (e.g., Tai Chi) showed the greatest positive impact on global cognitive function in healthy seniors (Cohen’s Effect Size d = 0.48), surpassing both purely aerobic or resistance forms. Aerobic exercises strongly correlated with improved executive functions (planning, attention), while resistance training effectively supported memory and showed the potential to attenuate cognitive decline in clinical populations. Recent evidence indicates that combined (multimodal) training, especially a combination of aerobic and resistance exercises, leads to synergistic and superior benefits for executive functions, which are further enhanced by the integration of cognitive training elements. Conclusions: Physical activity represents a critical non-pharmacological intervention. Combined training, which promotes both physical endurance and cognitive coordination, appears to be the most optimal strategy for maximizing and expanding cognitive benefits. Given the persistent knowledge gaps regarding optimal protocols (dose-response relationships) and underlying mechanisms, further high-quality research investigating the synergistic effects of multimodal interventions is needed.

17 July 2026 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
HBHubert Bigajski
Hubert Bigajski
FBFilip Basta
Filip Basta
KMKatarzyna Mostowska
Katarzyna Mostowska
ATAlicja Tomasiak
Alicja Tomasiak
KGKrystian Głąbiński
Krystian Głąbiński
MWMichał WęGrzyn
Michał WęGrzyn
Background. For decades, the male urinary tract was considered sterile. Next-generation sequencing (NGS) overturned this dogma, revealing a complex urobiome. Aim. This study aims to summarize literature on the physiological male urobiome and evaluate the impact of its dysbiosis on the pathogenesis of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) and benign prostatic hyperplasia (BPH). Material and methods. A narrative review was conducted using PubMed and Scopus, focusing on contemporary literature (2017–2025). Keywords included: male urobiome, urinary microbiome, chronic prostatitis, benign prostatic hyperplasia, dysbiosis. Case reports and animal models were excluded, prioritizing human clinical data and NGS-based analyses with rigorous negative controls. Results. The healthy male urobiome exhibits multi-species diversity (e.g., Corynebacterium, Streptococcus). In CP/CPPS, hidden dysbiosis replaces the sterility concept; anaerobic enrichment directly correlates with pain and inflammation. In BPH, dysbiosis acts as an inflammatory cofactor driving tissue growth. Urobiome destabilization is linked to metabolic syndrome and visceral obesity, generating systemic inflammation and exacerbating lower urinary tract symptoms (LUTS). Conclusions. Dysbiosis plays a pivotal role in CP/CPPS and BPH pathogenesis. Instead of ineffective empirical antibiotic therapy destroying commensal flora, modern strategies should rely on microbiome modulation (targeted probiotics) and biofilm eradication (bacteriophages for catheter infection prevention).

15 September 2026 in Lekarz Wojskowy
Verified
Journal Article
Open access
PDF file
DKDominik Ireneusz Kret
Dominik Ireneusz Kret
WSWiktoria Klaudia Szlachta
Wiktoria Klaudia Szlachta
KHKarolina Handzel
Karolina Handzel
AAAntoni Anczyk
Antoni Anczyk
FBFilip Basta
Filip Basta
JWJacek Wysoczański
Jacek Wysoczański
High-altitude cerebral oedema is one of the three forms of altitude sickness and is considered one of its most serious complications. Its incidence is relatively low, but its rapid progression and worsening symptoms make it a life-threatening condition that requires immediate medical attention. The growing popularity of high-altitude tourism means that knowledge about altitude sickness and high-altitude cerebral oedema should be promoted not only among medical professionals but also among ordinary tourists planning high-mountain expeditions. The following paper, which is a narrative review describing high-altitude cerebral oedema, discusses the key pathogenetic elements of this condition, including molecular mechanisms resulting from exposure to hypobaric hypoxia, blood-brain barrier dysfunction, increased vascular permeability, and the development of both vasogenic and cytotoxic oedema. Epidemiological data and risk factors are presented, followed by the spectrum of clinical manifestations, ranging from non-specific, mild symptoms that may coexist with an episode of acute mountain sickness to ataxia, impaired consciousness, and other severe neurological signs. The paper addresses diagnostic issues, with particular emphasis on the usefulness of imaging tests, specifically magnetic resonance imaging, in the process of confirming the diagnosis. Finally, the role of rapid implementation of appropriate therapy, consistent with current medical knowledge and consisting of altitude reduction, oxygen therapy, administration of steroids, and, in difficult conditions, the use of a portable hyperbaric chamber, is emphasised. High-altitude cerebral oedema remains a challenge that should always be managed by an interdisciplinary team; however, further research is needed to deepen our understanding of the pathophysiology, diagnosis, and treatment of this condition.